Management of Gynecological Cancers in Older Women PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Management of Gynecological Cancers in Older Women PDF full book. Access full book title Management of Gynecological Cancers in Older Women by Stuart M. Lichtman. Download full books in PDF and EPUB format.
Author: Stuart M. Lichtman
Publisher: Springer Science & Business Media
ISBN: 1447146050
Category : Medical
Languages : en
Pages : 418
Get Book Here
Book Description
This book aims to provide an up-to-date review of the literature in each of the major areas relating to the management of older gynecological cancer patients, and makes recommendations for best practice and future research. The authors come from a broad geographic spread including the UK, mainland Europe and North America to ensure a worldwide relevance.
Author: Stuart M. Lichtman
Publisher: Springer Science & Business Media
ISBN: 1447146050
Category : Medical
Languages : en
Pages : 418
Get Book Here
Book Description
This book aims to provide an up-to-date review of the literature in each of the major areas relating to the management of older gynecological cancer patients, and makes recommendations for best practice and future research. The authors come from a broad geographic spread including the UK, mainland Europe and North America to ensure a worldwide relevance.
Author: Gilles Freyer
Publisher: Springer
ISBN: 3319235885
Category : Medical
Languages : en
Pages : 106
Get Book Here
Book Description
This practical book provides up-to-date information on the particular features of ovarian cancer in older women and the best management approach. The full range of relevant topics is covered. Guidance is provided on geriatric assessment, screening, pathology, diagnosis, and follow-up. The various treatment options are carefully explained, covering surgical approaches, chemotherapy as a first-line strategy, the use of anti-angiogenic agents, and treatment of relapse. The cognitive problems that may arise in elderly women during and after treatment of ovarian cancer are documented, with advice on response. Guidance is also provided on the design of clinical trials, and current directions in biological research are reviewed. This book will be of value to both practitioners and researchers with an interest in ovarian cancer and the elderly.
Author: Jonathan A. Ledermann
Publisher: Springer Science & Business Media
ISBN: 0857299107
Category : Medical
Languages : en
Pages : 347
Get Book Here
Book Description
This is a novel text that highlights the controversial areas in the management of gynecological cancers. None of the topics in this book have definitive answers; they represent the everyday decision-making facing gynecologists, oncologists, radiologists, pathologists and other health professionals treating women with these conditions. This book is not to be used as a traditional textbook; it is a text that specialists and trainees will use to help them weigh up the arguments that exist in a variety of areas in the treatment of gynecological cancers. Each chapter will have two or more authors, selected either for their opposing views or for their ability to provide an opposite view or opinion to the other. The content will be evidence-based, illustrating contrasting evidence and scientific opinion in the literature. Each chapter will close on a summary indicating the direction of research needed to address the issues being discussed.
Author: Amy Klapheke
Publisher:
ISBN: 9780438930216
Category :
Languages : en
Pages :
Get Book Here
Book Description
Gynecologic cancers are an important problem in older American women. These patients may experience significant physical and mental problems that negatively impact their health-related quality of life (HRQOL). While HRQOL is becoming an increasingly important part of cancer research, relatively little is known about HRQOL in older women with gynecologic cancers. The objective of this dissertation was to characterize HRQOL in older American women with gynecologic cancer using the Surveillance, Epidemiology, and End Results – Medicare Health Outcomes Survey (SEER-MHOS) linked data resource. We identified female Medicare Advantage Organization enrollees who were at least 65 years old when diagnosed with a first primary invasive cervical, ovarian, or uterine cancer and participated in MHOS between 1998 and 2014. The three research studies in this dissertation each addressed a different aspect of HRQOL in older gynecologic cancer patients. The first study assessed the impact of depressive symptoms on HRQOL in women with gynecologic cancer versus matched cancer-free controls. We found that women with cancer were significantly more likely to screen positively for depression and that women with cancer and depressive symptoms had significantly worse HRQOL than cancer-free controls and women with no depressive symptoms. The second study evaluated the likelihood of developing functional impairments after cancer diagnosis and estimated pre- to post-diagnosis changes in HRQOL in women with cancer compared to a matched group of women without cancer. We determined that cancer patients, particularly those diagnosed at advanced stages, had significantly greater odds of functional impairment and experienced greater declines in HRQOL compared to controls. The third and final study examined the association between HRQOL, functional impairments, and depressive symptoms measured before cancer diagnosis with survival in older women with endometrial cancer. We observed that both physical and mental aspects of HRQOL were associated with survival and that women with worse HRQOL had significantly worse prognosis. Together these studies provide evidence of the significant impact that gynecologic cancer has on both physical and mental aspects of HRQOL in older women, and they underscore the need for tailored interventions to reduce pain, provide support, and prepare older women for changes in functioning and health after diagnosis with gynecologic cancer. Further, these findings demonstrate the value of HRQOL and other patient-reported outcomes in cancer research, as many physical and emotional problems cannot be measured by traditional laboratory tests. HRQOL measures can thus be used to better identify women with cancer who are at greatest risk of declining health, functional impairment, and depression. Assessment of HRQOL in cancer patients may help providers routinely monitor changes in physical and mental well-being, inform treatment decisions, and determine appropriate supportive care.
Author: Daniel Clarke-Pearson
Publisher: John Wiley & Sons
ISBN: 1444356372
Category : Medical
Languages : en
Pages : 285
Get Book Here
Book Description
This concise and practical guide enables the gynecologist to differentiate between benign and malignant gynecologic conditions to determine the best management options for the patient. Over the past three decades, as the specialty of obstetrics and gynecology has matured into a broad and diverse group of skills and disciplines, it has become apparent that there are diagnoses and conditions in gynecologic oncology where the obstetrician-gynecologist has a level of uncertainty, or lack of confidence in his ability or knowledge base to adequately manage the patient and therefore refers the patient to a gynecologic oncologist. This text portrays the advances in the field and reviews the current management of a number of gynaecologic conditions to give the reader the confidence needed to deal with these issues. The distinguides Editors have crafted the book to include: Case vignettes to provide clinical context Pathology notes to aid diagnostic outcomes Management guidance for obgyn practitioners to enable the best outcome for their patients Each topic is introduced with a concise overview followed by case-based scenarios which discuss the specific management of common problems. Providing the general gynecologist with the current clinical information necessary to manage conditions and identify the situations where consultation or referral to a gynecologic oncologist would be in the patient’s best interest.
Author: Marcela del Carmen
Publisher: John Wiley & Sons
ISBN: 1118655354
Category : Medical
Languages : en
Pages : 293
Get Book Here
Book Description
Rare gynecological cancers kill all too commonly Gynecological cancer is a frightening prospect for women. It is terrifying also for physicians who need, but often can’t find, guidance on how to investigate and appropriately treat the tumors. Rare cancers provide greater challenges as information can be harder to find and more difficult to verify. Rare Gynecologic Cancers: Diagnosis and Management brings together all you need to know on these life-threatening diseases. Straightforward summaries of pathophysiologic processes lead to the investigations that will improve your diagnostic accuracy. This provides the basis for you to identify effective treatment strategies for your patients. Written by a world-leading team of Editors and Authors and covering cancers of the • Ovaries • Uterus • Vulva • Vagina • Cervix Rare Gynecologic Cancers: Diagnosis and Management will guide you to the best life-saving treatment for your patients.
Author: Michael Frumovitz
Publisher: Elsevier Health Sciences
ISBN: 0323829392
Category : Medical
Languages : en
Pages : 387
Get Book Here
Book Description
Offering a one-stop guide to recognition and therapeutic decision making, Diagnosis and Treatment of Rare Gynecologic Cancers fills a gap in the medical literature on uncommon ovarian, uterine, cervical, and vulvovaginal cancers and trophoblastic diseases. This authoritative text, edited by Drs. Michael Frumovitz, Mario Leitao, and Preetha Ramalingam, has been authored by internationally recognized experts from top institutions such as MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Each chapter covers different cancer subtypes and has been reviewed by an oncologist and a pathologist. Provides up-to-date clinical guidance on assessment and therapeutic options for patients with rare gynecologic malignancies. Presents information in a templated, easy-to-read format. Each chapter includes an introductory clinical case followed by epidemiology of disease, pathologic assessment, basic science/molecular/translational research, work-up of newly diagnosed disease, staging, treatment of newly diagnosed disease, treatment of recurrent disease, potential therapeutic targets, and a case resolution. Includes diagnostic and treatment algorithms for each form of cancer. Contains numerous anatomical figures, radiographs, photographs, and tables for quick visual reference.
Author: Eric J. Bieber
Publisher: Cambridge University Press
ISBN: 1107040396
Category : Medical
Languages : en
Pages : 1127
Get Book Here
Book Description
Written with the busy practice in mind, this book delivers clinically focused, evidence-based gynecology guidance in a quick-reference format. It explores etiology, screening, tests, diagnosis, and treatment for a full range of gynecologic health issues. The coverage includes the full range of gynecologic malignancies, reproductive endocrinology and infertility, infectious diseases, urogynecologic problems, gynecologic concerns in children and adolescents, and surgical interventions including minimally invasive surgical procedures. Information is easy to find and absorb owing to the extensive use of full-color diagrams, algorithms, and illustrations. The new edition has been expanded to include aspects of gynecology important in international and resource-poor settings.
Author: Robert C. Bast, Jr.
Publisher: John Wiley & Sons
ISBN: 111900084X
Category : Medical
Languages : en
Pages : 2004
Get Book Here
Book Description
Holland-Frei Cancer Medicine, Ninth Edition, offers a balanced view of the most current knowledge of cancer science and clinical oncology practice. This all-new edition is the consummate reference source for medical oncologists, radiation oncologists, internists, surgical oncologists, and others who treat cancer patients. A translational perspective throughout, integrating cancer biology with cancer management providing an in depth understanding of the disease An emphasis on multidisciplinary, research-driven patient care to improve outcomes and optimal use of all appropriate therapies Cutting-edge coverage of personalized cancer care, including molecular diagnostics and therapeutics Concise, readable, clinically relevant text with algorithms, guidelines and insight into the use of both conventional and novel drugs Includes free access to the Wiley Digital Edition providing search across the book, the full reference list with web links, illustrations and photographs, and post-publication updates
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309380499
Category : Medical
Languages : en
Pages : 397
Get Book Here
Book Description
In an era of promising advances in cancer research, there are considerable and even alarming gaps in the fundamental knowledge and understanding of ovarian cancer. Researchers now know that ovarian cancer is not a single disease-several distinct subtypes exist with different origins, risk factors, genetic mutations, biological behaviors, and prognoses. However, persistent questions have impeded progress toward improving the prevention, early detection, treatment, and management of ovarian cancers. Failure to significantly improve morbidity and mortality during the past several decades is likely due to several factors, including the lack of research being performed by specific disease subtype, lack of definitive knowledge of the cell of origin and disease progression, and incomplete understanding of genetic and non-genetic risk factors. Ovarian Cancers examines the state of the science in ovarian cancer research, identifies key gaps in the evidence base and the challenges to addressing those gaps, considers opportunities for advancing ovarian cancer research, and examines avenues for translation and dissemination of new findings and communication of new information to patients and others. This study makes recommendations for public- and private-sector efforts that could facilitate progress in reducing the incidence of morbidity and mortality from ovarian cancers.
